Patrick Burgermeister is a partner of BioMedPartners, a Venture Capital company focussing of life science investments in central Europe. He joined their fund family in 2006 coming from Novartis where he was Senior Portfolio Manager of project management. There, he was responsible for the evaluation and prioritization of development projects from preclinical to registration stage.
Prior to Novartis, he was Senior Financial Analyst responsible for the European Biotech and Pharma sector at Zürcher Kantonalbank. In addition, he served as advisor to the healthcare fund Pharma Vision. Before that, he worked as strategic planning manager at Jomed AG (now Abbott Vascular).
Mr. Burgermeister also headed the business development at Apeiron Biologics (Vienna, Austria) where he was instrumental in several licensing deals. He also served as chariman of a Swiss dermatology startup.
Patrick Burgermeister holds a Master degree in Molecular Biology from the University of Basel (Biozentrum), a Master degree in Business Administration from the University of St. Gallen (HSG) and a degree as Chartered Financial Analyst (CFA).